Literature DB >> 2224669

Acute interstitial nephritis due to 5-aminosalicylic acid.

R P Mehta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2224669      PMCID： PMC1452481     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  [Acute interstitial nephritis caused by 5-aminosalicylic acid?].

Authors:  W Ruf-Ballauf; F Hofstädter; K Krentz
Journal:  Internist (Berl)       Date:  1989-04       Impact factor: 0.743

2.  [Chronic interstitial nephritis after treatment with 5-aminosalicylic acid].

Authors:  H V Henning; J Meinhold; T Eisenhauer; F Scheler; H J Gröne
Journal:  Dtsch Med Wochenschr       Date:  1989-07-07       Impact factor: 0.628

3.  Pathogenesis and therapy of interstitial nephritis.

Authors:  E G Neilson
Journal:  Kidney Int       Date:  1989-05       Impact factor: 10.612

Review 4.  Renal syndromes associated with nonsteroidal antiinflammatory drugs.

Authors:  D M Clive; J S Stoff
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

5.  Role of renal prostaglandins during antidiuresis and water diuresis in man.

Authors:  R M Walker; R S Brown; J S Stoff
Journal:  Kidney Int       Date:  1982-02       Impact factor: 10.612
  5 in total
  9 in total

1.  Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event.

Authors:  Pedro Magalhães-Costa; Leopoldo Matos; Cristina Chagas
Journal:  BMJ Case Rep       Date:  2015-05-02

2.  Late onset interstitial nephritis associated with mesalazine treatment.

Authors:  J Popoola; A F Muller; L Pollock; P O'Donnell; P Carmichael; P Stevens
Journal:  BMJ       Date:  1998-09-19

3.  Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.

Authors:  E A Masson; J M Rhodes
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

4.  Do gastroenterologists monitor their patients taking 5-amino-salicylates following initiation of treatment.

Authors:  N Siddique; C Farmer; A F Muller
Journal:  Frontline Gastroenterol       Date:  2014-06-04

5.  Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.

Authors:  S Schreiber; J Hämling; E Zehnter; S Howaldt; W Daerr; A Raedler; W Kruis
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

6.  Sulphasalazine induced renal failure.

Authors:  A D Dwarakanath; J Michael; R N Allan
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

7.  Renal effects of long-term treatment with 5-aminosalicylic acid.

Authors:  H Patel; A Barr; K N Jeejeebhoy
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

8.  Mesalazine induced interstitial nephritis.

Authors:  P J Thuluvath; M Ninkovic; J Calam; M Anderson
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

Review 9.  5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.

Authors:  James G Moss; Christopher M Parry; Richard C L Holt; Stephen J McWilliam
Journal:  Eur J Med Res       Date:  2022-04-29       Impact factor: 4.981
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.